Ciprofloxacin Tablet, Film Coated
Product Images NDC 82868-102

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Ciprofloxacin (NDC 82868-102). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (82868 102 14 Rev A 02 26 Nhc)

Label for Ciprofloxacin Tablets USP 250 mg, film-coated oral tablets, containing 14 tablets. The label indicates prescription use only, storage instructions, and manufacturing details by Northwind Health Company, LLC. NDC 82868-102-14 is displayed along with lot and expiration placeholders.*

FDA Label Image

Adult Dosage Guidelines (Adult Dosage Guidelines)

A data table listing various infections along with the recommended dose, frequency, and usual treatment durations for ciprofloxacin tablets. The table covers infections such as skin and skin structure, bone and joint, complicated intra-abdominal, infectious diarrhea, typhoid fever, urogenital infections, inhalational anthrax, plague, chronic bacterial prostatitis, lower respiratory tract infections, urinary tract infections, acute uncomplicated cystitis, and acute sinusitis.*

FDA Label Image

Pediatric Dosage Guidelines (Pediatric Dosage Guidelines)

A table titled 'Pediatric Dosage Guidelines' showing ciprofloxacin dosage recommendations for infections including complicated urinary tract or pyelonephritis (ages 1 to 17), inhalational anthrax post-exposure, and plague. It lists doses in mg/kg, frequency of administration, and total treatment duration in days.*

FDA Label Image

Logo 1 (Rising Logo)

FDA Label Image

Steady Pharmacokinetic (Steady Pharmacokinetic)

A data table titled 'Steady-state Pharmacokinetic Parameters Following Multiple Oral and Intravenous Doses (Adults)' comparing pharmacokinetic parameters of ciprofloxacin at various doses and administration routes. It presents parameters including AUC (area under the concentration-time curve) and Cmax (maximum concentration) for oral and intravenous dosing at different strengths and intervals.*

FDA Label Image

Ciprofloxacin-str1 (Ciprofloxacin Str1)

Chemical structure of ciprofloxacin showing its quinolone core with a fluorine atom and piperazine ring, including hydrochloride and water components.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.